+100%-

Geoff’s Narrations

The GIST

The Blog

 

brain on fire.

The study showed that pathogenic triggers in the brain impacted the muscles ability to do work.

It’s always seemed that both the brain and the muscles must be involved in diseases like chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), and long COVID. The question has always been how? A study just showed up could answer that question.

The problem starts in the brain, is triggered by an infection or a toxin that produces neuroinflammation, and somehow finds a way to impact the ability of the muscles to produce energy (!).

The new finding has birthed something called the brain-muscle axis. First, though, we look at the opposite: the muscle-brain axis.

THE GIST

  • It’s always seemed that both the brain and the muscles must be involved in diseases like chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), and long COVID. The question has always been how? A study just showed up could answer that question.
  • It originates in the brain, can be triggered by infection, is associated with neuroinflammation, and impacts the ability of the muscles to produce energy (!). The new finding has birthed something called the brain-muscle axis.
  • We’ve known for decades that the muscles are sending messages to the brain and affect things like energy metabolism, glucose metabolism, inflammation and bone formation.
  • In this study, the authors introduced a variety of triggers (bacterial infections, the SARS-CoV-2 protein ORF3a, and the neurotoxic protein Aβ42 found in Alzheimer’s) to produce neuroinflammation in the brains of the ubiquitous fruit fly and mice.
  • Note the interesting disease choices –  Alzheimer’s and long COVID – two diseases that are rarely mentioned together but both of which feature what the senior author of the study called “deep muscle fatigue“.
  • Each animal responded to the introduction of these substances with a clear increase in muscle fatigue and reduced endurance. Introducing these stressors into the brain triggered increased levels of reactive oxygen species (ROS), or free radicals which then triggered the production of the IL-6 cytokine, which then found its way to the muscles, where it turned on genes that turned down energy production.
  • For the first time, inflammation in the brain was shown to reduce muscle mitochondrial activity and endurance dramatically. No exercise was needed to shut down the muscles. All it took was neuroinflammation.
  • Noting that a lack of motivation does not play a role in this process, the senior author of the study stated: “This is more than a lack of motivation to move because we don’t feel well. These processes reduce energy levels in skeletal muscle, decreasing the capacity to move and function normally,”.
  • While the study was done in fruit flies and mice, note that this pathway appears to be highly evolutionarily conserved; i.e. this core pathway is present in many species.
  • Noting the large energy needs of the muscles, the authors proposed that when the brain is inflamed it may limit energy production by the muscles to give the brain more resources.
  • The two key factors needed for this process to occur – neuroinflammation and increased IL-6 levels – have been found in ME/CFS, fibromyalgia, and long COVID.
  • The authors proposed that IL-6 and Stat inhibitors could help, Avindra Nath has also proposed using JAK-STAT inhibitors in ME/CFS.
  • We don’t know if this process is occurring in ME/CFS, FM and long COVID, but one suspects that whatever ends up causing these diseases will impact an evolutionarily conserved core pathway that can dramatically affect functionality.
  • The good news is that a way to explain how neuroinflammation can directly impact energy production in the muscles has been found. The finding has received a lot of attention, and will undoubtedly hook in some Alzheimer’s researchers, and will undoubtedly be followed up on. The long-COVID/ME/CFS/fibromyalgia research world just got a bit richer and is bringing new potential treatment options to the table.

The Muscle-Brain Axis (???)

We’ve heard a lot about the gut-brain axis, but it turns out, there’s also a muscle-brain axis – and it’s no slouch. In their potentially groundbreaking study, “Infection and chronic disease activate a brain-muscle signaling axis that regulates muscle performance“, Yang et. al point out that we’ve known for decades that the muscles are constantly sending messages to the brain.

Sixty years ago, it also became clear that the muscles were regulating metabolism. By 2021, researchers had identified over 50 muscle-derived proteins that made it, and were impacting the brain. The muscles were pumping out so many compounds, in fact, that they came to be called an “endocrine organ”; i.e. they’re impacting many important processes in the body outside of the muscles – several of which involve energy production – a key issue in these energy-limiting diseases.

That includes increasing the ability of fats to produce energy, lipolysis (fat cell breakdown), glucose homeostasis, insulin secretion, anti-inflammation, angiogenesis, and bone formation. Concerning metabolism, the skeletal muscles have been called “the most critical organ involved in regulating whole-body glucose homeostasis”.

The impact the muscles have on the body as a whole is startling given that it’s always seemed that the muscles must be involved in fibromyalgia (“muscle-fiber” pain) and chronic fatigue syndrome (ME/CFS). We may have just begun to scratch the surface of the role they play in these diseases.

IL-6 – The Jekyll and Hyde Factor

The biggie in the muscle myokine (communication) family is a chemokine called IL-6 that’s produced in astonishing amounts (100-fold increases!) by the muscles during exertion.

IL-6 increases energy levels in the muscle by increasing the outflows of Ca2+ ions, thus enabling them to contract and do work. During exercise, glycogen depletion (the muscle’s energy source) and free radical production (reactive oxygen species) trip the signal to produce more IL-6.

IL-6 then stimulates fatty cells and tissues to release fats, and the liver to release glucose, to provide more energy. (Enhancing muscle-derived IL-6 levels is clearly one reason why exercise is so beneficial.)

IL-6, though, has a dark side. While muscle-derived IL-6 is anti-inflammatory, immune cell-derived IL-6 is associated with inflammation and, even worse, muscle energy depletion.

pathogens

The study used bacterial, viral, and toxic proteins to stress the central nervous system.

The Study

The authors introduced a variety of triggers (bacterial infections, the SARS-CoV-2 protein ORF3a, and the neurotoxic protein Aβ42 found in Alzheimer’s) to produce neuroinflammation in the brains of the ubiquitous fruit fly, and then moved on to mice.

Note the interesting disease choices –  Alzheimer’s and long COVID – two diseases that are rarely mentioned together but both of which feature what the senior author of the study called “deep muscle fatigue“.

“We are interested in understanding the very deep muscle fatigue that is associated with some common illnesses.”

Each animal responded to the introduction of these substances with a clear increase in muscle fatigue and reduced endurance. Determining how that happened resulted in the introduction of a new pathway – the brain-muscle axis.

The Brain-Muscle Axis is Born

We know that in a process called “central fatigue”, the brain affects muscle endurance by activating (or refusing to activate )the muscles, and that the Nath intramural study proposed that pathways in the brain are making exertion more effortful in ME/CFS.

Note how brain-oriented this is: in central fatigue, the brain may or may not be turning on the muscles, but the muscles themselves aren’t damaged.

All it took was neuroinflammation in the brain to whack the muscles.

All it took was neuroinflammation in the brain to whack the muscles.

This study suggested something very different can happen. Introducing these stressors into the brain triggered increased levels of reactive oxygen species (ROS), or free radicals. Lacking an electron in their outer shells, these unbalanced molecules rip electrons out of nearby molecules, producing damage.

The increased free radical levels in the brain triggered the production of the IL-6 cytokine, which then found its way to the muscles, where it activated the Jak-STAT gene transcription pathway.

The genes activated by the Jak-STAT pathway can either help build muscles up or tear them down. In this case, they reduced muscle mitochondrial activity, causing fatigue and reduced endurance. Note that no changes in muscle fiber makeup were found – it was all about energy production.

Thus, the authors reported, the brain-muscle axis was born. In this scenario, the brain is putting the brakes on the muscles but in a more direct way than has been seen before. For the first time, inflammation in the brain was shown to dramatically reduce muscle mitochondrial activity and endurance.

No exercise was needed to shut down the muscles. All it took was neuroinflammation.

While the study was done in fruit flies and mice, note that this pathway appears to be highly evolutionarily conserved; i.e. it’s a core pathway present in many species.

Lack of Functionality – Not Motivation

The authors’ statement regarding motivation echoed what people with ME/CFS have been saying for decades: they’re motivated. They usually have a long list of things they want to do but can’t. Reduced functionality-  not motivation – is what is holding things up. The authors couldn’t agree more.

“This is more than a lack of motivation to move because we don’t feel well. These processes reduce energy levels in skeletal muscle, decreasing the capacity to move and function normally,” said Dr. Aaron Johnson, senior author of the study.

Robbing Peter to Pay Paul

Muscle contraction

Neuroinflammation impaired the ability of muscles to contract and do work.

Lastly, they suggested why this strange process – the brain taking a veritable 2×4 to the muscle’s ability to produce energy – has been evolutionarily conserved across many organisms. It’s all about freeing up energy when needed.

With the muscles using up almost 30% of the body’s energy production at rest, and the immune system vacuuming up 45% of the body’s energy production during an infection, it makes sense, if neuroinflammation is present, to find a way to free up some energy to help heal the brain.

Turning down energy production in the muscles achieves that while reducing movement – a key part of the process of sickness behavior that results in people isolating themselves when they have an infection.

Mark Davis proposed that a similar process involving the immune system might be working in the opposite direction: the immune system is raiding energy stores and leaving the brain high and dry.

The Big Energy Sink? Pt. 2 – ME/CFS and Long COVID Study Suggests Immune Cells Robbing the Body of Energy

Another possibility is that signals of muscle damage to the brain are causing the brain to shut down the muscles so that they can heal.

Either explanation fits the ME/CFS, fibromyalgia, and long-COVID suite of diseases pretty well.

No Brain Infection Needed

The study demonstrated that it’s not necessary, as many have suspected, for the coronavirus to infect the brain to produce neuroinflammation. All it took, in this case, was for a protein that was able to make it past the blood-brain barrier and persist. All that may be needed to produce a disease like long COVID (or ME/CFS for that matter) are for pieces of the virus to remain.

roads lead to Rome; i.e. an ME/CFS-like state

This study and the Dubbo study suggest that a variety of pathogens (as well as toxins) are able to affect core processes that result in debilitating muscle fatigue.

Many Roads Lead to Rome

The study suggests that a number of different triggers (bacteria, coronavirus protein, neurotoxic protein) produce the same result – a nice finding for a disease like ME/CFS where triggers abound. Indeed, the authors proposed that this process may be present in a variety of infection-triggered, as well as chronic, diseases.

A Long-COVID / ME/CFS / Fibromyalgia Connection

With regard to long COVID, the authors proposed that the increased IL-6 levels found in mild cases of COVID-19 may set the stage for an ongoing activation of the brain-muscle pathway. Their finding that a single coronavirus protein in the brain (ORF3a) can get this process going provided a nice causal pathway for long COVID.

Johnson, the senior author, suggested that once this process gets going, it may become chronic.

“We also see evidence that this effect can become chronic. Even if an infection is cleared quickly, the reduced muscle performance remains many days longer in our experiments.”

Note that the key requirement is neuroinflammation, which Jarred Younger thinks will be wholly accepted in ME/CFS within the next year or so. Studies suggest it is present in fibromyalgia, as well.

The next key factor is an upregulation of IL-6 which has shown to be upregulated in COVID-19 and appears to play a role in fibromyalgia. Note that three types of IL-6 exist: central nervous system, immune system, and muscle-derived IL-6. The first one is both inflammatory and muscle-damaging; the second is inflammatory, and the third is anti-inflammatory.

IL-6 is not a new factor in fibromyalgia or ME/CFS. Several studies suggest that an IL-6 Jak/STAT pathway has been activated in fibromyalgia and that increased IL-6 levels in the cerebrospinal fluid and/or blood play a significant role in FM pain. One study suggests people with FM react more strongly to IL-6 as well. Plus, increased IL-6 levels may be associated with insulin resistance. Increased IL-6 levels have been found in ME/CFS several times but not always.

A long-COVID/ME/CFS study implicated 5 hub proteins, one of which was IL-6, in the two diseases. Increased levels of IL-6 were coupled with reductions in ATP production in long-COVID patients who met the diagnosis of ME/CFS. Pre-pandemic, IL-6 levels were associated with chronic fatigue. IL-6 levels have been found elevated in long COVID several times, and a systematic review concluded that “increased IL-6 correlates with long COVID“.

Treatment Possibilities

“In the meantime, we hope our study encourages more clinical research into this pathway and whether existing treatments that block various parts of it can help the many patients who experience this type of debilitating muscle fatigue.” Aaron Johnson

The authors proposed that IL-6 and Stat inhibitors could help, and mentioned the Stat inhibitor ruxolitinib, which has been approved to treat alopecia, psoriasis, lymphoma, and myelofibrosis.

“These clinical results argue that systemic treatment with IL-6 and JAK inhibitors could inhibit changes to muscle performance induced by the brain-muscle signaling axis and prevent muscle dysfunction associated with chronic and infectious diseases.”

Avindra Nath and Rob Phair have proposed that Jak-STAT inhibitors be trialed in ME/CFS, and Ely is trialing a Jak inhibitor in his big long COVID trial (thanks Shea and Bailey).

How Neuroinflammation May Be Knocking out the Muscles in Long COVID, ME/CFS and Fibromyalgia

Oddly, despite showing that an “ROS scavenger” (antioxidant) improved muscle performance in the flies with neuroinflammation, the authors didn’t mention using antioxidants to combat the oxidative stress in the brain. Theoharides has proposed that mast cell inhibitors can reduce IL-6 levels in fibromyalgia.

A small test of an IL-6 inhibitor, anakinra, however, failed to produce results in ME/CFS.

Conclusion

Brain puzzle

This study linked the brain and the muscles in a way that’s never been done before. (Image by Gerd Altman – Pixabay)

With their use of different bacterial, viral protein and neurotoxic triggers, the authors were clearly intent on delineating a new pathway that may be present in many diseases that feature “deep muscle fatigue”.

The study is reminiscent, in a way, of the Dubbo studies in the 1990s which demonstrated that widely differing bacteria and viral infections somehow ended up producing a very similar-looking ME/CFS-like illness. Researchers have been looking to find the core pathway to explain that ever since then.

Could this be it, or part of it? We don’t know, but one suspects that whatever ends up causing these diseases will look something like this. In other words, it will impact an evolutionarily conserved core pathway that can dramatically affect functionality.

Researchers and doctors who are introduced to these diseases are, after all, often shocked by the degree of disability found. Ditto with the inability to engage in what is almost a universal prescription – exercise. Something has gone wrong in a very fundamental way.

How ME/CFS and long COVID – with their post-exertional malaise – fit into all this is, of course, unclear. This pathway, if it does play a role in them, may be more accentuated in these diseases, or there may be add-on effects. Reduced muscle energy production would seem to account for difficulties exercising, but would it account for the post-exertional problems present?

One wonders as well how Paul Wang’s WASF3 ME/CFS finding – which also could explain reductions in muscle energy production – or how Rob Wust’s long-COVID finding – demonstrating that intense exercise caused muscle damage – might fit into this.

WASF3 – NIH Researchers Find New Mitochondrial Abnormality in ME/CFS

However it all fits together, the good news is that a way to explain how neuroinflammation can directly impact energy production in the muscles has been found. The finding has received a lot of attention, and will undoubtedly hook in some Alzheimer’s researchers, and will undoubtedly be followed up on. The long-COVID/ME/CFS/fibromyalgia research world just got a bit richer bringing new potential treatment options to the table.  (Thanks to Kristin for the tip about this study.)

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This